牙科骨移植替代材料市場－全球產業規模、佔有率、趨勢、機會和預測：按類型、材料、作用機制、產品類型、應用、最終用戶、地區和競爭格局分類，2021-2031年

全球牙科骨移植替代材料市場預計將從2025年的9.0828億美元顯著成長至2031年的14.1668億美元，複合年成長率（CAGR）為7.69%。這些特殊的生物材料可作為支架，促進天然骨再生，並在修復骨缺損的再生手術中發揮關鍵作用，例如人工植牙和牙周治療。這一成長主要受全球對牙齒替代解決方案日益成長的需求以及老齡化社會中牙周疾病患病率不斷上升的驅動。歐洲牙周病學會聯盟（European Federation of Societies of Periodontology）的報告凸顯了這一臨床需求的規模：到2024年，包括牙周炎和齲齒（蛀牙）在內的可預防性口腔疾病的治療費用將約佔全球醫療費用支出的5%，這凸顯了有效干預措施的巨大需求。

然而，儘管市場需求強勁，但由於再生醫學手術費用高昂且保險覆蓋範圍普遍不足，市場仍面臨許多限制。在許多地區，保險公司並未全額報銷這些先進療法，導致患者需承擔高額自付費用，從而限制了患者的就醫途徑，尤其是在新興經濟體。因此，高品質骨移植替代材料在低收入者中的廣泛應用受到經濟挑戰的限制。這種經濟障礙阻礙了成本敏感地區的市場潛力，並將先進移植療法的可及性限制在富裕患者群體中。

市場促進因素

骨移植替代材料市場的主要驅動力是全球人工植牙手術需求的激增。這使得植入的普及與骨再生材料的需求之間形成了直接的依賴關係。由於充足的骨量對於植入的穩定性至關重要，齒槽骨缺損的普遍存在使得骨移植材料的使用成為必要，使其成為現代修復牙科的重要組成部分。這一趨勢也體現在主要行業參與者的財務成功上。例如，士卓曼集團在其2025年2月發布的「2024年全年財務報告」中報告稱，其收入為25億瑞士法郎，內部成長率為13.7%，這主要得益於其強勁的植入業務。此外，美國牙醫協會（ADA）指出，截至2025年8月，美國消費者在牙科保健方面的支出成長了4%，顯示患者對修復牙科的投入持續成長。

第二個關鍵促進因素是與人口老化相關的無牙顎和重度牙周病病例的增加。老齡化自然會導致齒槽骨吸收，並增加患有損害顎骨結構的口腔疾病的風險，從而增加對骨重組治療的需求。重度牙周炎仍然是一項全球性的健康挑戰，世界衛生組織（世衛組織）在其2025年3月發布的《口腔健康》概況介紹中估計，全球將有超過10億例重度牙周病病例。這種疾病的嚴重程度凸顯了再生醫學介入的迫切性，隨著全球人口老化和複雜口腔健康問題的不斷演變，對有效骨移植替代物進行功能性修復的依賴必將增加。

市場挑戰

全球牙科骨移植替代材料市場成長的最大障礙是再生醫療手術的高昂費用和缺乏足夠的報銷。許多保險公司將先進的骨移植手術歸類為選擇性或美容手術，而非醫療必需項目，導致患者需要承擔高額的自付費用。這種經濟負擔嚴重阻礙了市場滲透，迫使很大一部分患者選擇更便宜的非修復性替代方案或無限期推遲治療。因此，骨移植替代材料的應用往往僅限於富裕人群，這限制了該市場在新興經濟體和成本敏感型經濟體中的潛在擴張。

這種經濟障礙導致患者接受專業牙科服務的動機顯著下降，造成了專業護理的瓶頸。根據美國牙醫協會 (ADA) 2024 年的報告，與其他醫療保健服務相比，牙科護理的費用障礙最為嚴重，導致只有 40% 的勞動年齡成年人會去看牙醫。這項數據凸顯了高成本與低利用率之間的直接關聯。當經濟拮据使患者甚至無法獲得基本的牙科服務時，對骨移植等高級、高成本手術的需求必然會受到抑制，從而阻礙整個市場的擴張。

市場趨勢

重塑市場格局的關鍵趨勢是數位化工作流程與引導性骨再生技術的融合，進而提升臨床精準度與治療效果。錐狀射束CT (CBCT) 與口內掃描的結合，使臨床醫生能夠利用軟體驅動的工具精確計算所需骨量並製作定製手術導板，顯著提高複雜牙槽骨增容手術的可預測性。該技術的快速普及也體現在行業業績上。士卓曼集團於2025年2月發布的2024年度報告顯示，其數位化解決方案業務在全球實現了兩位數的收入成長。這一成長印證了數位化互聯正成為常規植入和再生手術的標準組成部分。

同時，合成骨材和異種移植材料的使用正在加速發展，逐漸取代傳統的自體骨移植在骨增量手術的應用。這項轉變的驅動力主要來自臨床目標，即最大限度地減少與二次手術部位相關的患者併發症，以及高品質、即用型生物材料的普及，這些材料能夠提供有效的骨傳導支架。這一趨勢的商業性影響在財務表現中顯而易見。根據亨利·謝恩公司於2025年2月發布的“2024會計年度第四季度及全年財務業績”，其全球特種產品部門（包括生物材料）的銷售額達到14億美元，同比成長8.7%。這一成長表明，作為自體骨移植的替代方案，這些便捷的重組材料的需求持續強勁成長。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球牙科骨移植替代材料市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 按類型（同種異體移植、異質骨移植、自體移植、合成骨移植、其他）
  • 依材料分類（人源細胞、膠原蛋白、動物性、其他）
  • 透過作用機轉（骨傳導、骨誘導、骨促進、骨形成）
  • 依產品（BioOSS、Grafton、Osteograph）
  • 依應用領域（齒槽窩保存、齒槽嵴增高、牙周缺損再生、植入骨再生、鼻竇增高術）
  • 依最終使用者（醫院/診所、牙體技術所、其他）分類
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美牙科骨移植替代材料市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲牙科骨移植替代材料市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區牙科骨移植替代材料市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲牙科骨移植替代材料市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

10. 南美洲牙科骨移植替代材料市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球牙科骨移植替代材料市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Dentsply Sirona Inc.
• ZimVie Inc.
• Medtronic plc
• Institut Straumann AG
• Geistlich Pharma AG
• BioHorizons Inc.
• NovaBone Products, LLC
• Botiss Biomaterials GmbH
• LifeNet Health, Inc.
• RTI Surgical Holdings, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Dental Bone Graft Substitute Market is projected to experience substantial growth, expanding from USD 908.28 Million in 2025 to USD 1416.68 Million by 2031 at a CAGR of 7.69%. These specialized biomaterials function as scaffolds to facilitate natural bone regeneration, playing a critical role in restorative treatments such as dental implant placement and periodontal therapy to correct bone defects. This expansion is primarily driven by the rising global demand for tooth replacement solutions and the growing prevalence of periodontal diseases in an aging population. Underscoring the scale of this clinical need, the European Federation of Periodontology reported in 2024 that the treatment of preventable oral conditions, including periodontitis and caries, accounted for roughly 5% of global healthcare expenditures, highlighting the significant burden requiring effective restorative interventions.

However, despite strong demand, the market faces a major restraint due to the high cost of regenerative procedures and the frequent lack of comprehensive reimbursement policies. In many regions, insurance providers do not fully cover these advanced treatments, leading to substantial out-of-pocket expenses that limit patient access, particularly in emerging economies. As a result, affordability issues prevent the widespread adoption of premium bone graft substitutes among lower-income demographics. This economic barrier hampers market potential in cost-sensitive areas, restricting the reach of advanced grafting therapies to primarily affluent patient segments.

Market Driver

A primary catalyst for the bone graft substitute market is the surging global demand for dental implant procedures, which has established a direct dependency between implant adoption and the need for bone regeneration materials. Since adequate bone volume is essential for implant stability, the prevalence of ridge deficiencies necessitates the concurrent use of bone grafts, making them integral to modern restorative dentistry. This trend is reflected in the financial success of key industry players; for instance, Straumann Group's 'Full Year 2024 Annual Report', released in February 2025, reported revenues of CHF 2.5 billion with 13.7% organic growth, driven largely by its robust implantology business. Furthermore, the American Dental Association noted in 2025 that U.S. consumer dental spending rose by 4% through August, indicating sustained patient investment in restorative oral healthcare.

The second critical driver is the expanding geriatric population and the associated rise in edentulism and severe periodontal conditions. Aging naturally leads to alveolar bone resorption and increased susceptibility to oral diseases that compromise jaw structure, thereby fueling the necessity for reconstructive bone therapy. Severe periodontitis remains a pervasive global health challenge; the World Health Organization's 'Oral Health' fact sheet from March 2025 estimated that over 1 billion cases of severe periodontal disease exist worldwide. This vast scale of pathology highlights the urgent need for regenerative interventions, ensuring that as the global population ages and faces complex oral health issues, the reliance on effective bone graft substitutes for rehabilitation will continue to intensify.

Market Challenge

The most significant impediment to the growth of the Global Dental Bone Graft Substitute Market is the prohibitive cost of regenerative procedures coupled with the absence of adequate reimbursement frameworks. Many insurance providers classify advanced bone grafting as an elective or cosmetic service rather than a medical necessity, forcing patients to shoulder significant out-of-pocket costs. This financial burden severely restricts market penetration, as a large portion of the patient population is compelled to choose less expensive, non-restorative alternatives or delay treatment indefinitely. Consequently, the adoption of bone graft substitutes is often limited to wealthier demographics, preventing the market from realizing its full volume potential in emerging and cost-sensitive economies.

This economic barrier leads to a quantifiable decrease in patient engagement with professional dental services, creating a bottleneck for specialized care. According to the American Dental Association in 2024, dental care presented the highest cost barriers compared to other health services, contributing to a utilization rate where only 40% of working-age adults visited a dentist. This statistic underscores a direct link between high costs and low service uptake; when patients are unable to afford basic access to dental professionals due to financial constraints, the downstream demand for sophisticated, high-cost procedures like bone grafting is inevitably throttled, thereby stalling overall market expansion.

Market Trends

A major trend reshaping the market is the convergence of digital workflow and guided bone regeneration technologies, which are enhancing clinical precision and outcomes. By integrating cone-beam computed tomography (CBCT) and intraoral scanning, clinicians can leverage software-driven tools to calculate exact bone volume requirements and fabricate custom surgical guides, significantly improving the predictability of complex ridge augmentations. The rapid adoption of this technology is evidenced by industry performance; Straumann Group's 'Annual Report 2024', published in February 2025, highlighted double-digit revenue growth in its digital solutions business globally. This expansion confirms that digitized interconnectivity is becoming a standard component of routine implant and regenerative procedures.

Concurrently, there is an accelerated shift toward the use of synthetic and xenograft materials, which are displacing traditional autogenous bone harvesting as the preferred standard for augmentation. This transition is driven by the clinical goal of minimizing patient morbidity associated with secondary surgical sites and the availability of high-quality, off-the-shelf biomaterials that offer effective osteoconductive scaffolds. The commercial impact of this preference is clear in financial results; Henry Schein's 'Fourth Quarter and Full Year 2024 Financial Results' from February 2025 reported that their Global Specialty Products segment, encompassing biomaterials, achieved sales of $1.4 billion-an 8.7% increase from the prior year. This growth highlights the sustained momentum in the consumption of these convenient reconstructive materials over autografts.

Key Market Players

• Dentsply Sirona Inc.
• ZimVie Inc.
• Medtronic plc
• Institut Straumann AG
• Geistlich Pharma AG
• BioHorizons Inc.
• NovaBone Products, LLC
• Botiss Biomaterials GmbH
• LifeNet Health, Inc.
• RTI Surgical Holdings, Inc.

Report Scope

In this report, the Global Dental Bone Graft Substitute Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dental Bone Graft Substitute Market, By Type

• Allograft
• Xenograft
• Autograft
• Synthetic Bone Graft
• Others

Dental Bone Graft Substitute Market, By Material

• Human Cell Source
• Collagen
• Animal Source
• Others

Dental Bone Graft Substitute Market, By Mechanism

• Osteoconduction
• Osteoinduction
• Osteopromotion
• Osteogenesis

Dental Bone Graft Substitute Market, By Product

• Bio OSS
• Grafton
• Osteograf

Dental Bone Graft Substitute Market, By Application

• Socket Preservation
• Ridge Augmentation
• Periodontal Defect Regeneration
• Implant Bone Regeneration
• Sinus Lift

Dental Bone Graft Substitute Market, By End User

• Hospitals & Clinics
• Dental Laboratories
• Others

Dental Bone Graft Substitute Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dental Bone Graft Substitute Market.

Available Customizations:

Global Dental Bone Graft Substitute Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Dental Bone Graft Substitute Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Allograft, Xenograft, Autograft, Synthetic Bone Graft, Others)
  • 5.2.2. By Material (Human Cell Source, Collagen, Animal Source, Others)
  • 5.2.3. By Mechanism (Osteoconduction, Osteoinduction, Osteopromotion, Osteogenesis)
  • 5.2.4. By Product (Bio OSS, Grafton, Osteograf)
  • 5.2.5. By Application (Socket Preservation, Ridge Augmentation, Periodontal Defect Regeneration, Implant Bone Regeneration, Sinus Lift)
  • 5.2.6. By End User (Hospitals & Clinics, Dental Laboratories, Others)
  • 5.2.7. By Region
  • 5.2.8. By Company (2025)
• 5.3. Market Map

6. North America Dental Bone Graft Substitute Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Material
  • 6.2.3. By Mechanism
  • 6.2.4. By Product
  • 6.2.5. By Application
  • 6.2.6. By End User
  • 6.2.7. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Dental Bone Graft Substitute Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Material
      • 6.3.1.2.3. By Mechanism
      • 6.3.1.2.4. By Product
      • 6.3.1.2.5. By Application
      • 6.3.1.2.6. By End User
  • 6.3.2. Canada Dental Bone Graft Substitute Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Material
      • 6.3.2.2.3. By Mechanism
      • 6.3.2.2.4. By Product
      • 6.3.2.2.5. By Application
      • 6.3.2.2.6. By End User
  • 6.3.3. Mexico Dental Bone Graft Substitute Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Material
      • 6.3.3.2.3. By Mechanism
      • 6.3.3.2.4. By Product
      • 6.3.3.2.5. By Application
      • 6.3.3.2.6. By End User

7. Europe Dental Bone Graft Substitute Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Material
  • 7.2.3. By Mechanism
  • 7.2.4. By Product
  • 7.2.5. By Application
  • 7.2.6. By End User
  • 7.2.7. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Dental Bone Graft Substitute Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Material
      • 7.3.1.2.3. By Mechanism
      • 7.3.1.2.4. By Product
      • 7.3.1.2.5. By Application
      • 7.3.1.2.6. By End User
  • 7.3.2. France Dental Bone Graft Substitute Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Material
      • 7.3.2.2.3. By Mechanism
      • 7.3.2.2.4. By Product
      • 7.3.2.2.5. By Application
      • 7.3.2.2.6. By End User
  • 7.3.3. United Kingdom Dental Bone Graft Substitute Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Material
      • 7.3.3.2.3. By Mechanism
      • 7.3.3.2.4. By Product
      • 7.3.3.2.5. By Application
      • 7.3.3.2.6. By End User
  • 7.3.4. Italy Dental Bone Graft Substitute Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Material
      • 7.3.4.2.3. By Mechanism
      • 7.3.4.2.4. By Product
      • 7.3.4.2.5. By Application
      • 7.3.4.2.6. By End User
  • 7.3.5. Spain Dental Bone Graft Substitute Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Material
      • 7.3.5.2.3. By Mechanism
      • 7.3.5.2.4. By Product
      • 7.3.5.2.5. By Application
      • 7.3.5.2.6. By End User

8. Asia Pacific Dental Bone Graft Substitute Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Material
  • 8.2.3. By Mechanism
  • 8.2.4. By Product
  • 8.2.5. By Application
  • 8.2.6. By End User
  • 8.2.7. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Dental Bone Graft Substitute Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Material
      • 8.3.1.2.3. By Mechanism
      • 8.3.1.2.4. By Product
      • 8.3.1.2.5. By Application
      • 8.3.1.2.6. By End User
  • 8.3.2. India Dental Bone Graft Substitute Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Material
      • 8.3.2.2.3. By Mechanism
      • 8.3.2.2.4. By Product
      • 8.3.2.2.5. By Application
      • 8.3.2.2.6. By End User
  • 8.3.3. Japan Dental Bone Graft Substitute Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Material
      • 8.3.3.2.3. By Mechanism
      • 8.3.3.2.4. By Product
      • 8.3.3.2.5. By Application
      • 8.3.3.2.6. By End User
  • 8.3.4. South Korea Dental Bone Graft Substitute Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Material
      • 8.3.4.2.3. By Mechanism
      • 8.3.4.2.4. By Product
      • 8.3.4.2.5. By Application
      • 8.3.4.2.6. By End User
  • 8.3.5. Australia Dental Bone Graft Substitute Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Material
      • 8.3.5.2.3. By Mechanism
      • 8.3.5.2.4. By Product
      • 8.3.5.2.5. By Application
      • 8.3.5.2.6. By End User

9. Middle East & Africa Dental Bone Graft Substitute Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Material
  • 9.2.3. By Mechanism
  • 9.2.4. By Product
  • 9.2.5. By Application
  • 9.2.6. By End User
  • 9.2.7. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Dental Bone Graft Substitute Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Material
      • 9.3.1.2.3. By Mechanism
      • 9.3.1.2.4. By Product
      • 9.3.1.2.5. By Application
      • 9.3.1.2.6. By End User
  • 9.3.2. UAE Dental Bone Graft Substitute Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Material
      • 9.3.2.2.3. By Mechanism
      • 9.3.2.2.4. By Product
      • 9.3.2.2.5. By Application
      • 9.3.2.2.6. By End User
  • 9.3.3. South Africa Dental Bone Graft Substitute Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Material
      • 9.3.3.2.3. By Mechanism
      • 9.3.3.2.4. By Product
      • 9.3.3.2.5. By Application
      • 9.3.3.2.6. By End User

10. South America Dental Bone Graft Substitute Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Material
  • 10.2.3. By Mechanism
  • 10.2.4. By Product
  • 10.2.5. By Application
  • 10.2.6. By End User
  • 10.2.7. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Dental Bone Graft Substitute Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Material
      • 10.3.1.2.3. By Mechanism
      • 10.3.1.2.4. By Product
      • 10.3.1.2.5. By Application
      • 10.3.1.2.6. By End User
  • 10.3.2. Colombia Dental Bone Graft Substitute Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Material
      • 10.3.2.2.3. By Mechanism
      • 10.3.2.2.4. By Product
      • 10.3.2.2.5. By Application
      • 10.3.2.2.6. By End User
  • 10.3.3. Argentina Dental Bone Graft Substitute Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Material
      • 10.3.3.2.3. By Mechanism
      • 10.3.3.2.4. By Product
      • 10.3.3.2.5. By Application
      • 10.3.3.2.6. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Dental Bone Graft Substitute Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Dentsply Sirona Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. ZimVie Inc.
• 15.3. Medtronic plc
• 15.4. Institut Straumann AG
• 15.5. Geistlich Pharma AG
• 15.6. BioHorizons Inc.
• 15.7. NovaBone Products, LLC
• 15.8. Botiss Biomaterials GmbH
• 15.9. LifeNet Health, Inc.
• 15.10. RTI Surgical Holdings, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer